EVGN

NASDAQ Healthcare

Evogene Ltd. - Ordinary Shares

Biotechnology

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.

๐Ÿ“Š Market Data
Price$0.59
Volume24,623,394
Market Cap6.14M
Beta0.800
RSI (14-Day)22.6 Oversold
200-Day MA$1.02
50-Day MA$0.77
52-Week High$2.42
52-Week Low$0.52
Forward P/E-0.74
Price / Book-65.57
๐ŸŽฏ Investment Strategy Scores

EVGN scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
High growth potential (high beta + oversold)
Contrarian plays (oversold + below moving average)
Overbought stocks (potential short candidates)
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ”ช Falling Knife (98/100) โ€” this strategy Contrarian plays (oversold + below moving average).

Lowest fit among scored strategies: ๐ŸŽˆ Over-Hyped (3/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find EVGN in your text

Paste any article, transcript, or post โ€” the tool will extract EVGN and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-06-02.